BioSpace News Archive

Drug Development

Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering

Daiichi Sankyo Europe GmbH announced that results from the 12-week, pivotal Phase 3 bempedoic acid / ezetimibe FDC tablet study (also known as Study 053) were published in the European Journal of Preventative Cardiology.

July 31, 2019
·
6 min read
European CNS specialist Neuraxpharm launches first products in the United Kingdom

Craig Bowen appointed as General Manager of Neuraxpharm UK

July 31, 2019
·
3 min read
Drug Development

Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis

Atlantic Healthcare plc, a specialist pharmaceutical company focused on acquiring, developing and commercializing therapeutics that address unmet patient needs and rare diseases, announced the results of the Phase 3 trial of Camligo™ for orphan-designated pouchitis.

July 31, 2019
·
5 min read
Deals

MyoKardia to Report Second Quarter 2019 Financial Results on Wednesday, August 7, 2019

MyoKardia, Inc., announced that it will report second quarter 2019 financial and operating results on Wednesday, August 7, 2019.

July 31, 2019
·
2 min read
FDA

Merck’s Keytruda Has Been Approved for 20+ Indications, With the Latest Being for Esophageal Cancer

The U.S. Food and Drug Administration approved the anti-PD-1 therapy as a monotherapy for patients with recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus whose tumors express PD-L1 with disease progression after one or more previous lines of systemic therapy.

July 31, 2019
·
3 min read
·
Mark Terry
Business

Alexandria Real Estate Equities Plans Another Boston Life Sciences Lab Facility

The site “represents a strategic opportunity to expand Alexandria’s unparalleled, world-class” life science development in the Boston area, said Peter Moglia, co-chief executive officer and co-chief investment officer of Alexandria.

July 31, 2019
·
2 min read
·
Mark Terry
Chamber of Commerce Study Weighs in On HHS’s International Pricing Index Model Policy

Earlier this year, the U.S. Department of Health and Human Services proposed a new policy called the International Pricing Index, which would set specific drug prices based on an international benchmark.

July 31, 2019
·
5 min read
·
Mark Terry
Bio NC

Cities and Regions Invest in the Life Sciences to Bolster Economic Growth

Many cities, regions and states have an interest in developing the life sciences as being drivers of the economy, creating good-paying jobs both directly and indirectly. Here’s a look at recent news concerning some of these efforts around the country.

July 31, 2019
·
3 min read
·
Mark Terry
Policy

HHS Announces Possible Roadmap for Importing Drugs from Canada

As reported yesterday, the Trump administration is evaluating proposals to allow consumers to buy drugs legally from Canada. Today, their efforts became more official as the U.S. Department of Health and Human Services announced their intentions.

July 31, 2019
·
4 min read
·
Mark Terry
Business

Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer

Arvinas, Inc., a biotechnology company creating a new class of drugs based on targeted protein degradation, announced the appointment of Ronald Peck, M.D. to the newly created position of Chief Medical Officer.

July 31, 2019
·
5 min read